Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it has enclosed the schedule of Analyst Institutional Investor Meetings with the Company will be held on 23rd December 2020 with IIFL Institutional Equities. The schedule of the meeting is subject to change and the change may occur due to exigencies on the part of Investor / Company.
The above information is a part of company’s filings submitted to BSE.
